Teva Debuts US Azopt Rival
Brinzolamide 1% Ophthalmic Suspension Developed And Manufactured By Indoco
Teva has launched the first and so far only US generic version of Novartis’ Azopt treatment for ocular hypertension, with the brinzolamide 1% solution having been developed and manufactured by Indoco Remedies.
